Table 2.

Comparison of clinical symptoms data between the two groups of patients.

Clinical symptom information		Observation group (n = 20)	Control group (n = 88)	$\chi$2/t	p
Dysmenorrhea (n, %)				9.281	0.002
	Yes	15 (75.00%)	33 (37.50%)
	No	5 (25.00%)	55 (62.50%)
Dyspareunia (n, %)				9.255	0.002
	Yes	12 (60.00%)	22 (25.00%)
	No	8 (40.00%)	66 (75.00%)
Pelvic pain (n, %)				8.294	0.004
	Yes	11 (55.00%)	20 (22.73%)
	No	9 (45.00%)	68 (77.27%)
Painful defecation (n, %)				1.207	0.272*
	Yes	7 (35.00%)	18 (20.45%)
	No	13 (65.00%)	70 (79.55%)
Painful urination (n, %)				0.258	0.612*
	Yes	5 (25.00%)	15 (17.05%)
	No	15 (75.00%)	73 (82.95%)
Infertility (n, %)				0.601	0.438*
	Yes	5 (25.00%)	13 (14.77%)
	No	15 (75.00%)	75 (85.23%)
VAS (points)		8.05 $\pm$ 1.36	5.22 $\pm$ 1.18	9.409	0.001
DAS28 (points)		6.80 $\pm$ 1.20	4.25 $\pm$ 0.87	10.978	0.001
PSQI (points)		14.40 $\pm$ 2.01	9.67 $\pm$ 1.46	12.140	0.001
HAQ-DI (points)		2.40 $\pm$ 0.75	1.24 $\pm$ 0.43	9.318	0.001

Note: VAS, Visual Analog Scale; DAS28, Rheumatoid arthritis disease activity; PSQI, Pittsburgh Sleep Quality Index; HAQ-DI, Health Assessment Questionnaire-Disability Index; *, the continuity correction chi-square test was used.